• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Director Handlon Carolyn B was granted 13,689 shares, increasing direct ownership by 44% to 44,614 units (SEC Form 4)

    5/19/25 1:40:38 PM ET
    $IVR
    Real Estate Investment Trusts
    Real Estate
    Get the next $IVR alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Handlon Carolyn B

    (Last) (First) (Middle)
    1331 SPRING STREET, NW
    SUITE 2500

    (Street)
    ATLANTA GA 30309

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Invesco Mortgage Capital Inc. [ IVR ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    05/15/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock, par value $0.01 per share 05/15/2025 A 13,689 A $0 44,614 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    Remarks:
    This Form 4 reports the acquisition by the reporting person of Common Stock resulting from an equity grant to the registrant's non-executive directors.
    /s/ Rebecca Smith, as Attorney-in-Fact 05/19/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $IVR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $IVR

    DatePrice TargetRatingAnalyst
    6/6/2024$10.00Buy
    Janney
    12/6/2023$8.00Neutral
    UBS
    10/20/2023Neutral
    BTIG Research
    3/10/2022$3.00 → $2.29Underperform
    Credit Suisse
    More analyst ratings

    $IVR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Janney initiated coverage on Invesco Mortgage Capital with a new price target

      Janney initiated coverage of Invesco Mortgage Capital with a rating of Buy and set a new price target of $10.00

      6/6/24 7:17:23 AM ET
      $IVR
      Real Estate Investment Trusts
      Real Estate
    • UBS initiated coverage on Invesco Mortgage Capital with a new price target

      UBS initiated coverage of Invesco Mortgage Capital with a rating of Neutral and set a new price target of $8.00

      12/6/23 7:55:42 AM ET
      $IVR
      Real Estate Investment Trusts
      Real Estate
    • BTIG Research initiated coverage on Invesco Mortgage Capital

      BTIG Research initiated coverage of Invesco Mortgage Capital with a rating of Neutral

      10/20/23 7:26:24 AM ET
      $IVR
      Real Estate Investment Trusts
      Real Estate

    $IVR
    SEC Filings

    See more
    • INVESCO MORTGAGE CAPITAL INC filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits

      8-K - Invesco Mortgage Capital Inc. (0001437071) (Filer)

      6/24/25 4:34:39 PM ET
      $IVR
      Real Estate Investment Trusts
      Real Estate
    • SEC Form 10-Q filed by INVESCO MORTGAGE CAPITAL INC

      10-Q - Invesco Mortgage Capital Inc. (0001437071) (Filer)

      5/7/25 5:19:21 PM ET
      $IVR
      Real Estate Investment Trusts
      Real Estate
    • INVESCO MORTGAGE CAPITAL INC filed SEC Form 8-K: Results of Operations and Financial Condition, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

      8-K - Invesco Mortgage Capital Inc. (0001437071) (Filer)

      5/7/25 4:45:00 PM ET
      $IVR
      Real Estate Investment Trusts
      Real Estate